GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.

An Illinois jury sided with Boehringer Ingelheim in a Zantac cancer lawsuit. Learn about the legal angles, previous trial ...

Veterinarians on Prince Edward Island who have been monitoring the spread of avian influenza for years are encouraged by the ...

For the study, published in Open Forum Infectious Diseases, a team led by a University of Virginia (UVA) researcher and PRIME ...

Belgium plans to reinforce its global competitiveness in clinical research as the new government sets an ambitious course for pharma progress.

Britain's blue-chip FTSE 100 kicked off the week higher on Monday, boosted by heavyweight healthcare and defence stocks, on ...

The FTSE 100 index saw an uptick, driven by healthcare and defence stocks, bouncing back from a four-day downturn. BAE ...

GSK (GSK) plc announces the commencement of its share buyback program, as announced in its 2024 full year results announcement published on 5 ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...

Friday’s weak performance by US equities means London’s FTSE 100 index is set for a subdued start to the new week. The FTSE ...

GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...

The company's consolidated net profit jumped multifold to Rs 230 crore as compared to Rs 46 crore a year ago in the December ...